Clinical Trial Update: Birinapant With 5-azacitidine in MDS Subjects Who Are Naïve, Have Relapsed or Are Refractory to 5-azacitidine Therapy [Phase 1, Phase 2]

View source ↗

Summary

Completed Phase 1/2 clinical trial evaluating birinapant in combination with azacitidine for patients with myelodysplastic syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndrome

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Birinapant

Snippet

Sponsor: TetraLogic Pharmaceuticals | Conditions: Myelodysplastic Syndrome | Phase 1, Phase 2 | Status: COMPLETED